Showing results (401-410 of 623) with videos related to

Sort By:
Pageof 63
Cancers|July 27, 2022
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?Kai Jannusch, Nils Martin Bruckmann, Charlotte Johanna Geuting, et al.
Molecular Imaging and Biology|October 12, 2010
Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRIKen Herrmann, Ralph A Bundschuh, Robert Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective studyKatja Ott, Ken Herrmann, Florian Lordick, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus RecommendationLale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
18F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaJoseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
La Radiologia Medica|August 28, 2025
Recent advances in PET/MR imaging for head and neck tumors: a systematic review of the last three yearsDaniele Antonio Pizzuto, Minerva Becker, Patrick Veit-Haibach, et al.
Annals of Clinical and Translational Neurology|September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging studyJoachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Cancers|March 29, 2023
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast CancerKai Jannusch, Ann-Kathrin Bittner, Nils Martin Bruckmann, et al.
Pageof 63